tech
When Charisma Costs $100 Million: Orion Therapeutics’ Data‑Blind CEO Debacle
Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before making health decisions. Hook Imagine a board that thinks "visionary charisma" can replace a proven drug-development pedigree. In early 2022, Orion Therapeutics did exactly that, appointing